Harvard Bioscience
HBIO
HBIO
67 hedge funds and large institutions have $8.39M invested in Harvard Bioscience in 2025 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 27 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
42% less capital invested
Capital invested by funds: $14.5M → $8.39M (-$6.12M)
65% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 37
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
67
Holding in Top 10
–
Calls
$61K
Puts
$10K
Top Buyers
| 1 | +$341K | |
| 2 | +$284K | |
| 3 | +$61K | |
| 4 |
MIM
Meros Investment Management
Dallas,
Texas
|
+$55.6K |
| 5 |
AE
AMH Equity
Great Neck,
New York
|
+$53.9K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$757K | |
| 3 | -$627K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$264K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$214K |
